The price of Nutrien Ltd (NYSE: NTR) closed at $54.59 in the last session, down -1.60% from day before closing price of $55.48. In other words, the price has decreased by -$0.89 from its previous closing price. On the day, 1660358 shares were traded.
Ratios:
We take a closer look at NTR’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 28.69 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 10.47. For the most recent quarter (mrq), Quick Ratio is recorded 0.65 and its Current Ratio is at 1.17. In the meantime, Its Debt-to-Equity ratio is 0.50 whereas as Long-Term Debt/Eq ratio is at 0.39.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on March 26, 2024, initiated with a Buy rating and assigned the stock a target price of $62.
On March 01, 2024, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $66.
Piper Sandler Downgraded its Neutral to Underweight on February 29, 2024, whereas the target price for the stock was revised from $68 to $54.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NTR now has a Market Capitalization of 27.22B and an Enterprise Value of 38.85B. As of this moment, Nutrien’s Price-to-Earnings (P/E) ratio for their current fiscal year is 21.64, and their Forward P/E ratio for the next fiscal year is 13.03. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.93 while its Price-to-Book (P/B) ratio in mrq is 1.07. Its current Enterprise Value per Revenue stands at 1.34 whereas that against EBITDA is 7.95.
Stock Price History:
Over the past 52 weeks, NTR has reached a high of $75.29, while it has fallen to a 52-week low of $47.90. The 50-Day Moving Average of the stock is 52.62, while the 200-Day Moving Average is calculated to be 57.32.
Shares Statistics:
According to the various share statistics, NTR traded on average about 2.11M shares per day over the past 3-months and 2.29M shares per day over the past 10 days. A total of 494.55M shares are outstanding, with a floating share count of 494.37M. Insiders hold about 0.04% of the company’s shares, while institutions hold 71.10% stake in the company. Shares short for NTR as of Mar 15, 2024 were 3.12M with a Short Ratio of 1.48, compared to 1.61M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.63% and a Short% of Float of 0.63%.
Dividends & Splits
The forward annual dividend rate for NTR is 2.13, which was 2.12 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 3.82%, it implies a Forward Annual Dividend Yield of 4.03%. The stock’s 5-year Average Dividend Yield is 3.33. The current Payout Ratio is 82.84% for NTR, which recently paid a dividend on Apr 11, 2024 with an ex-dividend date of Mar 27, 2024. Stock splits for the company last occurred on Jan 02, 2018 when the company split stock in a 0:1 ratio.
Earnings Estimates
The company has 15 analysts who recommend its stock at the moment. On average, analysts expect EPS of $0.4 for the current quarter, with a high estimate of $0.73 and a low estimate of $0.22, while EPS last year was $1.11. The consensus estimate for the next quarter is $2.28, with high estimates of $2.74 and low estimates of $1.87.
Analysts are recommending an EPS of between $4.61 and $3.29 for the fiscal current year, implying an average EPS of $4.01. EPS for the following year is $4.44, with 17 analysts recommending between $5.63 and $3.45.
Revenue Estimates
According to 8 analysts, the current quarter’s revenue is expected to be $5.31B. It ranges from a high estimate of $5.76B to a low estimate of $5.04B. As of the current estimate, Nutrien Ltd’s year-ago sales were $5.91B, an estimated decrease of -10.20% from the year-ago figure. For the next quarter, 8 analysts are estimating revenue of $10.88B, a decrease of -2.20% over than the figure of -$10.20% in the same quarter last year. There is a high estimate of $11.6B for the next quarter, whereas the lowest estimate is $10.16B.
A total of 17 analysts have provided revenue estimates for NTR’s current fiscal year. The highest revenue estimate was $30.53B, while the lowest revenue estimate was $25.86B, resulting in an average revenue estimate of $27.6B. In the same quarter a year ago, actual revenue was $28.08B, down -1.70% from the average estimate. Based on 17 analysts’ estimates, the company’s revenue will be $28.21B in the next fiscal year. The high estimate is $31.91B and the low estimate is $25.84B. The average revenue growth estimate for next year is up 2.20% from the average revenue estimate for this year.
